More Articles

Clinical

Breaking new ground in healthcare data

Andrew Stone, (Apr 16, 2020)

Pharma should team up with HCPs, regulators and health ministries to create harmonised, interoperable health records and so drive cheaper, faster insights
Patients and Medical

Building a bridge to a COVID-19 vaccine

Andrew Stone, (Apr 15, 2020)

Regeneron shares its latest progress on therapies for the pandemic at eyeforpharma Philadelphia virtual
Access and Evidence

From reactive to predictive: Concerto’s new compositions

Andrew Stone, (Apr 10, 2020)

Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Clinical

Moving remote: the post-pandemic clinical trial

Lucy Fulford, (Apr 3, 2020)

Pharma is rapidly adapting its approach to trials in the face of the pandemic and there is great opportunity for far reaching improvements once this is all over
Patients and Medical

How should pharma approach patient collaboration in the 2020s?

Lucy Fulford, (Apr 1, 2020)


Deeper, more holistic, strategic and ‘patient directed’ engagement will be a win for all this coming decade
Multichannel

COVID-19 is accelerating digital transformation

Andrew Stone, (Apr 1, 2020)

Digital capabilities are proving their worth in the face of the sudden upheavals driven by the pandemic and ongoing investment will pay dividends, says Bertrand Bodson, Novartis CDO
Medical

Leading the hunt for a COVID-19 vaccine

Andrew Stone, (Apr 1, 2020)

J&J gives the inside track on the search for a COVID-19 vaccine at eyeforpharma’s Barcelona conference
Multichannel

Virtual Trade Show Best Practices: Intelligent Medical Objects and HiMSS

Paul Schrimpf, (Mar 28, 2020)

A new way of thinking and acting is needed for virtual marketing in the post COVID-19 world, says Paul Schrimpf of management consultant Prophet
Patients and Medical

Patients and RWE: Is this the year?

Tom Disley, (Mar 26, 2020)

There is reason to hope that the long-awaited breakthroughs flowing from patient-generated data are about to happen
Access and Evidence

Evolving HTA frameworks to accelerate innovation

Andrew Stone, (Mar 14, 2020)

Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague

Pages